1 / 12

Insulin Delivery Devices - Share, Trends, Size Analysis to 2020

Diabetes is a disease characterized by high blood sugar levels. It is caused by the improper functioning of the pancreas that secretes insulin. Insulin is a hormone that maintains blood sugar levels in the body and helps in the proper functioning of all cellular and physiological activities. Insulin delivery devices, such as insulin pens, pumps, syringes, and jet injectors, play a vital role in maintaining insulin levels in the body. Globally, insulin delivery devices market is growing rapidly due to increasing prevalence of diabetes and rising obese endemic. Additionally, advanced features of insulin delivery devices and rising awareness among people about diabetes care are also supporting in growth of the global insulin delivery devices market. The global insulin delivery devices market is estimated at USD 9,391.1 million in 2014 and is expected to grow at a CAGR of 7% from 2014 to 2020, to reach USD 14,093.3 million by 2020.

justinbarnes12
Download Presentation

Insulin Delivery Devices - Share, Trends, Size Analysis to 2020

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Insulin Delivery Devices Market driven by: Increasing prevalence of diabetes and obesity and others Persistence Market Research Insulin Delivery Devices market will rise from US$9,391.1 mn in 2014 to US$14,093.3 mn by 2020 - Persistence Market Research Persistence Market Research 1

  2. Insulin Delivery Devices Market driven by: Increasing prevalence of diabetes and obesity and others Persistence Market Research Released New Market Report “Global Market Study on Insulin Delivery Devices: Asia to Witness Highest Growth by 2020”, Persistence Market Research states that the market for insulin delivery devices is anticipated to expand at a healthy CAGR of 7.0% from 2014 to 2020. If this holds true, the value of the global market will rise from US$9,391.1 mn in 2014 to US$14,093.3 mn by 2020. Request Customize Full TOC: http://www.persistencemarketresearch.com/toc/2823 Even with the increasing number of factors fueling the insulin delivery devices market, high cost of insulin analog and complications and risks associated with the delivery of insulin are anticipated to impede the growth of the global market. However, trends such as development of home infusion therapy and artificial pancreas are gaining popularity, which is sure to boost the insulin delivery devices market in the coming years. The insulin delivery devices market is segmented on the basis of device into insulin pens, insulin jet injectors, insulin syringes, and insulin pumps. Request Sample Report: http://www.persistencemarketresearch.com/samples/2823 Different regional markets for insulin delivery devices are driven by various factors and the research report offers an in-depth analysis of the forces that govern the growth of each regional segment. The five regions covered in the global insulin delivery devices market are North America, Latin America, Asia, Europe, and Rest of the World. North America accounts for the largest share of the overall insulin delivery devices market and is anticipated to retain its lead throughout the forecast period. The growth in this region can be attributed to rise in geriatric population, alarming prevalence of diabetes, and surging number of obese and overweight population. The Latin America insulin delivery devices market is fueled by the establishment of several manufacturing and research facilities in the region. Persistence Market Research 2

  3. Insulin Delivery Devices Market driven by: Increasing prevalence of diabetes and obesity and others Asia, identified as having immense potential for future growth, is a market that is gaining prominence when it comes to insulin delivery devices. This development can be attributed to growing awareness about diabetes and the various treatment options, rise in aging population, support from government in the form of healthcare initiatives, and increasing prevalence of diabetes. Browse Full Report: http://www.persistencemarketresearch.com/market-research/insulin-delivery- device-market.asp The Europe insulin delivery devices market is driven by factors similar to those fueling the North America market: increase in aging population, technological advances in the delivery of insulin, growing prevalence of diabetes, and rising awareness among the patient population regarding treatment of diabetes. The most prominent players competing in the global insulin delivery devices market include Animas Corporation, B. Braun Melsungen AG, Insulet Corporation, Novo Nordisk A/S, Medtronic, Inc., Becton, Dickinson and Company, Sanofi, Abbott Laboratories, Eli Lilly and Company, F. Hoffmann-La Roche, Ltd., and Ypsomed Holding AG. These players are profiled in the research report based on factors such as company overview, products and services, recent developments, and financial performance. Market History: Diabetes is a disease characterized by high blood sugar levels. It is caused by the improper functioning of the pancreas that secretes insulin. Insulin is a hormone that maintains blood sugar levels in the body and helps in the proper functioning of all cellular and physiological activities. Insulin delivery devices, such as insulin pens, pumps, syringes, and jet injectors, play a vital role in maintaining insulin levels in the body. Globally, insulin delivery devices market is growing rapidly due to increasing prevalence of diabetes and rising obese endemic. Additionally, advanced features of insulin delivery devices and rising awareness among people about diabetes care are also supporting in growth of the global insulin delivery devices market. The global insulin delivery devices market is estimated at USD 9,391.1 million in 2014 and is expected to grow at a CAGR of 7% from 2014 to 2020, to reach USD 14,093.3 million by 2020. Persistence Market Research 3

  4. Insulin Delivery Devices Market driven by: Increasing prevalence of diabetes and obesity and others North America has the largest market share, followed by Europe and Asia, in the global insulin delivery devices market. The global insulin delivery devices market was valued at 7,300.0 million in 2010 and it expanded to USD 8,793.2 million in 2013. Table of Content Chapter 1 Preface 1.1 Report Description 1.2 Report Methodology 1.3 Assumptions Chapter 2 Market Synopsis Chapter 3 Porter’s Five Forces Analysis 3.1 Bargaining Power of Suppliers 3.2 Bargaining Power of Buyers Persistence Market Research 4

  5. Insulin Delivery Devices Market driven by: Increasing prevalence of diabetes and obesity and others 3.3 Threat of New Entrants 3.4 Threat of Substitutes 3.5 Intensity of Rivalry Chapter 4 Industry Overview 4.1 Market Definition 4.2 Market Drivers 4.2.1 Increasing prevalence of diabetes enhance the market growth 4.2.2 Globally rising obesity is increasing the prevalence of diabetes 4.2.3 Advanced features of insulin delivery devices attract end users 4.2.4 Rising awareness among people about diabetes care 4.3 Impact Analysis of Market Drivers 4.4 Market Restraints 4.4.1 Risk and complications associated with delivery of insulin 4.4.2 High cost of insulin analog impedes the market growth 4.5 Impact Analysis of Market Restraints 4.6 Market Trends 4.6.1 Artificial pancreas is gaining popularity in the insulin delivery devices market 4.6.2 Home infusion therapy is gaining importance in treatment of diabetes Chapter 5 Global Market Size and Forecast Chapter 6 Market Size and Forecast by Device 6.1 Insulin Syringes 6.2 Insulin Pens 6.3 Insulin Pumps 6.4 Insulin Jet Injectors Chapter 7 Market Size and Forecast by Geography 7.1 North America 7.1.1 Scenario in the U.S. 7.1.2 Scenario in Canada 7.2 Europe 7.2.1 Scenario in Germany 7.2.2 Scenario in France Persistence Market Research 5

  6. Insulin Delivery Devices Market driven by: Increasing prevalence of diabetes and obesity and others 7.2.3 Scenario in the U.K. 7.2.4 Scenario in Italy 7.2.5 Scenario in Spain 7.3 Asia 7.3.1 Scenario in Japan 7.3.2 Scenario in China 7.3.3 Scenario in India 7.4 Latin America 7.4.1 Scenario in Brazil Chapter 8 Competitive Scenario 8.1 Market Share Analysis 8.2 Competitive Benchmarking Chapter 9 Company Profiles 9.1 Abbott Laboratories 9.1.1 Company Overview 9.1.2 Products and Services 9.1.3 Financial Performance 9.1.4 Recent Developments 9.2 Novo Nordisk A/S 9.2.1 Company Overview 9.2.2 Products and Services 9.2.3 Financial Performance 9.2.4 Recent Developments 9.3 Eli Lilly and Company 9.3.1 Company Overview 9.3.2 Products and Services 9.3.3 Financial Performance 9.3.4 Recent Developments 9.4 Medtronic, Inc. 9.4.1 Company Overview 9.4.2 Products and Services 9.4.3 Financial Performance 9.4.4 Recent Developments Persistence Market Research 6

  7. Insulin Delivery Devices Market driven by: Increasing prevalence of diabetes and obesity and others 9.5 Sanofi 9.5.1 Company Overview 9.5.2 Products and Services 9.5.3 Financial Performance 9.5.4 Recent Developments 9.6 Becton, Dickinson and Company 9.6.1 Company Overview 9.6.2 Products and Services 9.6.3 Financial Performance 9.6.4 Recent Developments 9.7 F. Hoffmann-La Roche, Ltd. 9.7.1 Company Overview 9.7.2 Products and Services 9.7.3 Financial Performance 9.7.4 Recent Developments 9.8 Insulet Corporation 9.8.1 Company Overview 9.8.2 Products and Services 9.8.3 Financial Performance 9.8.4 Recent Developments 9.9 Ypsomed Holding AG 9.9.1 Company Overview 9.9.2 Products and Services 9.9.3 Financial Performance 9.9.4 Recent Developments 9.10 Animas Corporation 9.10.1 Company Overview 9.10.2 Products and Services 9.10.3 Financial Performance 9.10.4 Recent Developments 9.11 B. Braun Melsungen AG 9.11.1 Company Overview 9.11.2 Products and Services 9.11.3 Financial Performance 9.11.4 Recent Developments Persistence Market Research 7

  8. Insulin Delivery Devices Market driven by: Increasing prevalence of diabetes and obesity and others List of Tables TABLE 1 Market Snapshot: Global market for insulin delivery devices (2014 and 2020) TABLE 2 Drivers of insulin delivery devices market: Impact analysis TABLE 3 Restraints for insulin delivery devices market: Impact analysis TABLE 4 Global market for insulin delivery devices, by geography, 2010 – 2013 (USD million) TABLE 5 Global market for insulin delivery devices, by geography, 2014 – 2020 (USD million) TABLE 6 Global market for insulin delivery devices, by device, 2010 – 2013 (USD million) TABLE 7 Global market for insulin delivery devices, by device, 2014 – 2020 (USD million) TABLE 8 Global market for insulin syringes, by geography, 2010 – 2013 (USD million) TABLE 9 Global market for insulin syringes, by geography, 2014 – 2020 (USD million) TABLE 10 Global market for insulin pen, by geography, 2010 – 2013 (USD million) TABLE 11 Global market for insulin pen, by geography, 2014 – 2020 (USD million) TABLE 12 Global market for insulin pumps, by geography, 2010 – 2013 (USD million) TABLE 13 Global market for insulin pumps, by geography, 2014 – 2020 (USD million) TABLE 14 Global market for insulin jet injectors, by geography, 2010 – 2013 (USD million) TABLE 15 Global market for insulin jet injectors, by geography, 2014 – 2020 (USD million) TABLE 16 The North American market for insulin delivery devices, by country, 2010 – 2013 (USD million) TABLE 17 The North American market for insulin delivery devices, by country, 2014 – 2020 (USD million) TABLE 18 The North American market for insulin delivery devices, by device, 2010 – 2013 (USD million) TABLE 19 The North American market for insulin delivery devices, by device, 2014 – 2020 (USD million) TABLE 20 The U.S. market for insulin delivery devices, by device, 2010 – 2013 (USD million) TABLE 21 The U.S. market for insulin delivery devices, by device, 2014 – 2020 (USD million) TABLE 22 Canadian market for insulin delivery devices, by device, 2010 – 2013 (USD million) TABLE 23 Canadian market for insulin delivery devices, by device, 2014 – 2020 (USD million) TABLE 24 The European market for insulin delivery devices, by country, 2010 – 2013 (USD million) TABLE 25 The European market for insulin delivery devices, by country, 2014 – 2020 (USD million) TABLE 26 The European market for insulin delivery devices, by device, 2010 – 2013 (USD million) Persistence Market Research 8

  9. Insulin Delivery Devices Market driven by: Increasing prevalence of diabetes and obesity and others TABLE 27 The European market for insulin delivery devices, by device, 2014 – 2020 (USD million) TABLE 28 German market for insulin delivery devices, by device, 2010 – 2013 (USD million) TABLE 29 German market for insulin delivery devices, by device, 2014 – 2020 (USD million) TABLE 30 French market for insulin delivery devices, by device, 2010 – 2013 (USD million) TABLE 31 French market for insulin delivery devices, by device, 2014 – 2020 (USD million) TABLE 32 The U.K. market for insulin delivery devices, by device, 2010 – 2013 (USD million) TABLE 33 The U.K. market for insulin delivery devices, by device, 2014 – 2020 (USD million) TABLE 34 Italian market for insulin delivery devices, by device, 2010 – 2013 (USD million) TABLE 35 Italian market for insulin delivery devices, by device, 2014 – 2020 (USD million) TABLE 36 Spanish market for insulin delivery devices, by device, 2010 – 2013 (USD million) TABLE 37 Spanish market for insulin delivery devices, by device, 2014 – 2020 (USD million) TABLE 38 The Asian market for insulin delivery devices, by country, 2010 – 2013 (USD million) TABLE 39 The Asian market for insulin delivery devices, by country, 2014 – 2020 (USD million) TABLE 40 The Asian market for insulin delivery devices, by device, 2010 – 2013 (USD million) TABLE 41 The Asian market for insulin delivery devices, by device, 2014 – 2020 (USD million) TABLE 42 Japanese market for insulin delivery devices, by device, 2010 – 2013 (USD million) TABLE 43 Japanese market for insulin delivery devices, by device, 2014 – 2020 (USD million) TABLE 44 Chinese market for insulin delivery devices, by device, 2010 – 2013 (USD million) TABLE 45 Chinese market for insulin delivery devices, by device, 2014 – 2020 (USD million) TABLE 46 Indian market for insulin delivery devices, by device, 2010 – 2013 (USD million) TABLE 47 Indian market for insulin delivery devices, by device, 2014 – 2020 (USD million) TABLE 48 The Latin American market for insulin delivery devices, by country, 2010 – 2013 (USD million) TABLE 49 The Latin American market for insulin delivery devices, by country, 2014 – 2020 (USD million) TABLE 50 The Latin American market for insulin delivery devices, by device, 2010 – 2013 (USD million) TABLE 51 The Latin American market for insulin delivery devices, by device, 2014 – 2020 (USD million) TABLE 52 Brazilian market for insulin delivery devices, by device, 2010 – 2013 (USD million) TABLE 53 Brazilian market for insulin delivery devices, by device, 2014 – 2020 (USD million) TABLE 54 Abbott’s major product categories Persistence Market Research 9

  10. Insulin Delivery Devices Market driven by: Increasing prevalence of diabetes and obesity and others TABLE 55 Novo Nordisk’s product segments TABLE 56 Lilly’s product segments TABLE 57 Medtronic’s product segments TABLE 58 Sanofi’s major product categories TABLE 59 BD’s product segments TABLE 60 Roche’s product categories TABLE 61 Insulet’s product category TABLE 62 Ypsomed’s product categories TABLE 63 Animas’s major product categories TABLE 64 B. Braun product divisions List of Figures FIG. 1 Insulin delivery devices market: Porter\'s five forces analysis FIG. 2 Major insulin delivery devices FIG. 3 Emerging insulin delivery technologies FIG. 4 Number of people with diabetes mellitus (20 – 79 years) in major countries, 2010 and 2030 (million) FIG. 5 Prevalence of overweight and obese males aged 30 and above, 2005 and 2015 (%) FIG. 6 Prevalence of overweight and obese females aged 30 and above, 2005 and 2015 (%) FIG. 7 Global insulin delivery devices market share, by region, by value, 2013 FIG. 8 Global insulin delivery devices market share, by device, by value, 2013 FIG. 9 Global insulin syringes market share, by region, by value, 2013 FIG. 10 Global insulin pens market share, by region, by value, 2013 FIG. 11 Global insulin pumps market share, by region, by value, 2013 FIG. 12 Global insulin jet injectors market share, by region, by value, 2013 FIG. 13 The North American insulin delivery devices market share, by country, by value, 2013 FIG. 14 The North American insulin delivery devices market share, by device, by value, 2013 FIG. 15 The U.S. insulin delivery devices market share, by device, by value, 2013 FIG. 16 Prevalence of diabetes mellitus in people aged 20 – 79, 2010 and 2030 (thousand) FIG. 17 Canadian insulin delivery devices market share, by device, by value, 2013 FIG. 18 The European insulin delivery devices market share, by country, by value, 2013 FIG. 19 The European insulin delivery devices market share, by device, by value, 2013 FIG. 20 German insulin delivery devices market share, by device, by value, 2013 Persistence Market Research 10

  11. Insulin Delivery Devices Market driven by: Increasing prevalence of diabetes and obesity and others FIG. 21 French insulin delivery devices market share, by device, by value, 2013 FIG. 22 The U.K. insulin delivery devices market share, by device, by value, 2013 FIG. 23 Italian insulin delivery devices market share, by device, by value, 2013 FIG. 24 Spanish insulin delivery devices market share, by device, by value, 2013 FIG. 25 The Asian insulin delivery devices market share, by country, by value, 2013 FIG. 26 The Asian insulin delivery devices market share, by device, by value, 2013 FIG. 27 Japanese insulin delivery devices market share, by device, by value, 2013 FIG. 28 Chinese insulin delivery devices market share, by device, by value, 2013 FIG. 29 Indian insulin delivery devices market share, by device, by value, 2013 FIG. 30 The Latin American insulin delivery devices market share, by country, by value, 2013 FIG. 31 The Latin American insulin delivery devices market share, by device, by value, 2013 FIG. 32 Brazilian insulin delivery devices market share, by device, by value, 2013 FIG. 33 Market share analysis of insulin delivery devices market, by value, 2013 FIG. 34 Competitive landscape of insulin delivery devices market FIG. 35 Abbott net sales and net earnings, 2011 – 2013 (USD million) FIG. 36 Novo Nordisk net sales and net profit, 2011 – 2013 (USD million) FIG. 37 Lilly revenue and net income, 2011 – 2013 (USD million) FIG. 38 Medtronic net sales and net earnings, 2011 – 2013 (USD million) FIG. 39 Sanofi net sales and net profit, 2011 – 2013 (USD million) FIG. 40 BD revenue and net income, 2011 – 2013 (USD Million) FIG. 41 Roche Group sales and net income, 2011 – 2013 (USD Million) FIG. 42 Insulet revenue and net income, 2011 – 2013 (USD Million) FIG. 43 Ypsomed sales and net profit, 2011 – 2013 (USD Million) FIG. 44 B. Braun sales and consolidated net profit, 2011 – 2013 (USD Million) About Us: Persistence Market Research (PMR) is a full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. PMR boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients’ business needs. Persistence Market Research 11

  12. Insulin Delivery Devices Market driven by: Increasing prevalence of diabetes and obesity and others PMR stands committed to bringing more accuracy and speed to clients’ business decisions. From ready- to-purchase market research reports to customized research solutions, PMR’s engagement models are highly flexible without compromising on its deep-seated research values. Contact Us: Addie Thomes 305 Broadway 7th Floor, New York City, NY 10007, United States, USA - Canada Toll Free: 800-961-0353 Email: sales@persistencemarketresearch.com Web: http://www.persistencemarketresearch.com Persistence Market Research 12

More Related